Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

HIV/AIDS

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Boston Globe Examines How PEPFAR Budget Pressures Are Affecting AIDS Clinics In Africa

“U.S. officials have asked some AIDS clinics overseas to stop enrolling new patients in a U.S.-sponsored program that provides lifesaving antiretroviral drugs, in a bid to stem the rising costs of one of the most ambitious US assistance programs, according to interviews with doctors and official correspondence,” the Boston Globe reports.

Recent Releases In Global Health

Partners In Health Co-Founder Lectures On Global Health Topics The Dartmouth reports on a recent talk by Dartmouth College President Jim Yong Kim, co-founder of Partners In Health. During his lecture, which touched on several global health-related topics, “Kim stressed the need to incorporate ‘health care delivery science’ into undergraduate…

Cities, Leaders Worldwide Mark World Health Day

Cities throughout the world are marking World Health Day today by promoting urban health, as part of the WHO’s “1,000 cities, 1,000 lives” campaign, CNN reports (Shaikh, 4/7).

Also In Global Health News: E. Africa Counterfeit Drugs; CDC’s EIS; HIV Antibodies; Measles In Zimbabwe; Agriculture In Rwanda; Recovered Global Fund Money

Groups In E. Africa Warn Anti-Counterfeit Policy Will Compromise Patients’ Access To Medicines “East African countries risk not attaining the Millennium Development Goal (MDG) on universal treatment of people living with HIV and AIDS, malaria and other diseases if the region’s parliament adopts the anti-counterfeits policy and bill currently under…

60 Minutes Examines PEPFAR In Uganda

CBS News’ 60 Minutes reports from Uganda about how PEPFAR has helped people living with HIV/AIDS throughout the country and the challenges Uganda still faces in fighting the spread of the virus. The show includes interviews with Peter Mugyenyi of the Joint Clinical Research Center in Kampala, Uganda, and other doctors on the ground, who discuss how HIV-positive children and adults are alive today as a result of PEPFAR and how the program has helped to improve the way Africans view the United States.

Also In Global Health News: Iraq’s Health System; HIV Travel Restrictions; India Cholera Vaccine; HIV/AIDS Prevention In Indonesia; U.S. Federal Quarantine Regulations

IRIN Examines ‘Long And Complicated’ Process To Developing Iraq’s Health System IRIN examines how decades of conflict in Iraq have stymied development of the country’s health system. The piece includes comments by Iraqi Health Minister Salih al-Hasnawi, who describes the process of “developing [the country's health facilities] to reach international…

NewsHour Examines Research Of HIV Positive Patients Who Can Suppress The Virus

PBS’ NewsHour examines how a team of U.S. researchers are heading up a study in Lima, Peru, of patients living with HIV whose immune systems are able to supress the virus. “Peru has identified 600 so-called elites, whose HIV infections have not progressed into life-threatening AIDS, and researchers are looking at them and other identified elites from around the world to understand why,” according to the program.

Recent Releases In Global Health

Community Groups Offer Cost-Effective Mechanism For Reducing Maternal Mortality “Achieving the [Millennium Development Goal] MDG 4 target of reducing newborn and child mortality will require concerted efforts to scale up evidence-based interventions, especially community-based preventive and therapeutic strategies in primary care,” according to a Lancet comment that reflects on the challenges associated…

Bloomberg Examines Potential Benefits, Drawbacks To PrEP

“Gilead Sciences Inc. may learn this year whether its drugs for treating HIV can also stop people from catching the virus in the first place,” Bloomberg writes in a piece that examines the potential benefits and drawbacks to using low-doses of HIV/AIDS medications to reduce a person’s risk of becoming infected with HIV. According to the news service, the initial results of 10 trials including more than 20,000 people could be available as early as July.